1

Insightful Innovation

R&D innovation is the key to an enterprise's sustainable global competitiveness. Striving to embrace an innovation-driven MPI, we continue to invest in R&D, integrate R&D resources and make technology breakthroughs to satisfy the demands of patients and safeguard healthcare for all.

Explore more

 

R&D innovation system

Mindray has established a medical product innovation (MPI) system in line with its features and has optimized it constantly. With years of application and iteration, the system has become more efficient and developed. It is designed to improve our performance in projects, products and portfolios, and systematically add innovation impetus to our development.

Mindray is committed to making breakthrough in the most cutting-edge medical core technologies. Therefore, we have made considerable investment in research institutions, R&D personnel and R&D funds, and developed an innovative platform based on global resource allocation. We focus on cultivating innovation leaders and building a high-quality R&D talent team. The extraordinary and young R&D teams provide Mindray with strong innovation power and guarantee our R&D strength.

0
R&D centers

0
R&D experts

0
annual revenue spent on R&D

0
patent applications acquired in total

About0
patents are recognized by USA and EU

0 employees
have a master’s degree or above

 

Smart healthcare

Following the eco-R&D strategy, we make use of advanced resources, clinical experience and cooperate with industrial partners to expand equipment IoT, promote innovative development of medical scenarios and make healthcare more accessible.

 

Intellectual property protection

As a "National Intellectual Property Model Enterprise" , we have established a sound global intellectual property management system, which was granted the "Intellectual Property Management System Certificate" , to safeguard our independent intellectual property. In strict accordance with the Patent Law of the People's Republic of China, the Trademark Law of the People's Republic of China, the Management Standards for the Intellectual Property of Enterprises and laws & regulations of countries and regions where we operate, we have formulated and implemented multiple internal manuals and regulations to optimize out layout of intellectual property.

Mindray's Hematology R&D won the China Patent Gold Award.

2013

Mindray's Ultrasound R&D won the State Technological Innovation Award.

2018

Mindray's Ultrasound R&D won the China Patent Gold Award.

2020

Mindray Hematology R&D won the National Science and Technology Awards for Invention.

2021

As of Q1 2023, Mindray has applied for a total of 0 patents, including 0 invention patents; and authorized a total of 0 patents, including 0 invention patents.

Mindray's Ultrasound R&D won the State Technological Innovation Award.

2018

Mindray Hematology R&D won the National Science and Technology Awards for Invention.

2021

As of Q1 2023, Mindray has applied for a total of 0 patents, including0 invention patents; and authorized a total of 10 patents, including 10 invention patents.